Enhanced fibrinolysis protects against lung ischemia-reperfusion injury

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 5, 2009, Pages 1241-1248

  Lau, Christine L ^a   Zhao, Yunge ^a   Kim, Jiyoun ^b   Kron, Irving L ^a   Sharma, Ashish ^a   Yang, Zequan ^a   Laubach, Victor E ^a   Linden, Joel ^a   Ailawadi, Gorav ^a   Pinsky, David J ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Internal Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; FIBRIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; GENE EXPRESSION; HISTOLOGY; IMMUNOBLOTTING; INFLAMMATION; ISCHEMIA; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; WESTERN BLOTTING; WILD TYPE;

ACUTE LUNG INJURY; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROBABILITY; RANDOM ALLOCATION; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY;

EID: 64649096605     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.12.029     Document Type: Article

References (18)

1. Meyers B.F., de la Morena M., Sweet S.C., Trulock E.P., Guthrie T.J., Mendeloff E.N., et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 129 (2005) 1421-1429
2. Christie J.D., Kotloff R.M., Pochettino A., Arcasoy S.M., Rosengard B.R., Landis J.R., et al. Clinical risk factors for primary graft failure following lung transplantation. [see comment]. Chest 124 (2003) 1232-1241
3. Daud S.A., Yusen R.D., Meyers B.F., Chakinala M.M., Walter M.J., Aloush A.A., et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 175 (2007) 507-513
4. Fiser S.M., Tribble C.G., Long S.M., Kaza A.K., Kern J.A., Jones D.R., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73 (2002) 1041-1047 discussion 1047-8
5. Ware L.B., Camerer E., Welty-Wolf K., Schultz M.J., and Matthay M.A. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291 (2006) L307-L311
6. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31 4 Suppl (2003) S213-S220
7. Pinsky D.J., Liao H., Lawson C.A., Yan S.F., Chen J., Carmeliet P., et al. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 102 (1998) 919-928
8. Zhao M., Fernandez L.G., Doctor A., Sharma A.K., Zarbock A., Tribble C.G., et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 291 (2006) L1018-L1026
9. Zhao Y.-G., Xiao A.-Z., Newcomer R.G., Park H.I., Kang T., Chung L.W.K., et al. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 278 (2003) 15056-15064
10. Zhao Y.-G., Xiao A.-Z., Park H.I., Newcomer R.G., Yan M., Man Y.-G., et al. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res 64 (2004) 590-598
11. Nemzek J.A., Siddiqui J., and Remick D.G. Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Meth 255 (2001) 149-157
12. Abdel-Fattah R., Xiao A., Bomgardner D., Pease C.S., Lopes M.B.S., and Hussaini I.M. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes. J Pathol 209 (2006) 15-24
13. Okada K., Fujita T., Minamoto K., Liao H., Naka Y., and Pinsky D.J. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J Biol Chem 275 (2000) 21468-21476
14. Farivar A., Delgado M., McCourtie A., Barnes A., Verrier E., and Mulligan M.S. Crosstalk between thrombosis and inflammation in lung reperfusion injury. Ann Thorac Surg 81 (2006) 1061-1067
15. Christie J.D., Robinson N., Ware L.B., Plotnick M., De Andrade J., Lama V., et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 175 (2007) 69-74
16. Moalli R., Doyle J.M., Tahhan H.R., Hasan F.M., Braman S.S., and Saldeen T. Fibrinolysis in critically ill patients. Am Rev Respir Dis 140 (1989) 287-293
17. Brown N.J., Agirbasli M., and Vaughan D.E. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension 34 (1999) 285-290
18. Vaughan D.E., Rouleau J.L., Ridker P.M., Arnold J.M., Menapace F.J., and Pfeffer M.A. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation 96 (1997) 442-447